Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders ; volume:6 ; number:1 ; day:27 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (27.12.2018), 1-10, 12.2018

Creator: Boilève, A.
Carlo, M. I.
Barthélémy, P.
Oudard, S.
Borchiellini, D.
Voss, M. H.
George, S.
Chevreau, C.
Landman-Parker, J.
Tabone, M-D
Chism, D. D.
Amin, A.
Bilen, M. A.
Bosse, D.
Coulomb-L’hermine, A.
Su, Xiaoping
Choueiri, T. K.
Tannir, Nizar M.
Malouf, Gabriel G.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40425-018-0482-z

URN: urn:nbn:de:101:1-2019021416254024186685

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Boilève, A.
Carlo, M. I.
Barthélémy, P.
Oudard, S.
Borchiellini, D.
Voss, M. H.
George, S.
Chevreau, C.
Landman-Parker, J.
Tabone, M-D
Chism, D. D.
Amin, A.
Bilen, M. A.
Bosse, D.
Coulomb-L’hermine, A.
Su, Xiaoping
Choueiri, T. K.
Tannir, Nizar M.
Malouf, Gabriel G.
SpringerLink (Online service)

Other Objects (12)

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Abschnitt

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Abschnitt

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Abschnitt

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Xp11.2 translocation renal cell carcinomas in young adults

Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas

Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors

Identification of responders to immune checkpoint therapy : which biomarkers have the highest value?

Exceptional dynamics at exceptional points

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

Translocation

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Related objects

Reset password